Details for New Drug Application (NDA): 213543
✉ Email this page to a colleague
The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 213543
| Tradename: | TRIAMCINOLONE ACETONIDE |
| Applicant: | Long Grove Pharms |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Pharmacology for NDA: 213543
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 213543
Suppliers and Packaging for NDA: 213543
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | INJECTABLE;INJECTION | 213543 | ANDA | Long Grove Pharmaceuticals, LLC | 81298-5781 | 81298-5781-5 | 25 VIAL, SINGLE-USE in 1 CARTON (81298-5781-5) / 1 mL in 1 VIAL, SINGLE-USE (81298-5781-1) |
| TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | INJECTABLE;INJECTION | 213543 | ANDA | Long Grove Pharmaceuticals, LLC | 81298-5783 | 81298-5783-3 | 1 VIAL, MULTI-DOSE in 1 CARTON (81298-5783-3) / 10 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 40MG/ML | ||||
| Approval Date: | Jan 19, 2022 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
